Dexamethasone, Granisetron, or Both for the Prevention of Nausea and Vomiting during Chemotherapy for Cancer
Author:
- The Italian Group for Antiemetic ResearchTRThe Italian Group for Antiemetic Research
Open Access
- 5 January 1995
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (1) , 1-5
Abstract
Serotonin-receptor antagonists seem to be as effective as corticosteroids in preventing emesis induced by moderately emetogenic antineoplastic agents. We compared the antiemetic effect of a combination of granisetron and dexamethasone with that of granisetron or dexamethasone administered alone.Keywords
This publication has 14 references indexed in Scilit:
- Reducing Chemotherapy-Induced Nausea and Vomiting Current Perspectives and Future PossibilitiesDrug Safety, 1993
- Ondansetron vs dexamethasone for chemotherapy-induced emesisThe Lancet, 1991
- A randomized double-blind comparison of ondansetron and metoclopramide in the prophylaxis of emesis induced by cyclophosphamide, fluorouracil, and doxorubicin or epirubicin chemotherapy.Journal of Clinical Oncology, 1990
- A comparison of ondansetron with metoclopramide in the prophylaxis of chemotherapy-induced nausea and vomiting: A randomized, double-blind studyEuropean Journal of Cancer, 1990
- Effective Control of CMF-Related Emesis with High-Dose DexamethasoneAmerican Journal of Clinical Oncology, 1989
- A Double-Blind Trial Comparing Antiemetic Efficacy and Toxicity of Metoclopramide Versus Methylprednisolone Versus Domperidone in Patients Receiving Doxorubicin Chemotherapy Alone or in Combination with Other Antiblastic AgentsAmerican Journal of Clinical Oncology, 1988
- Methylprednisolone versus Metoclopramide for Prevention of Nausea and Vomiting in Breast Cancer Patients Treated with Intravenous Cyclophosphamide Methotrexate 5-Fluorouracil: A Double-Blind Randomized StudyOncology, 1988
- Double-blind controlled trial of the antiemetic efficacy and toxicity of methylprednisolone (MP), metoclopramide (MTC) and domperidone (DMP) in breast cancer patients treated with i.v. CMFEuropean Journal of Cancer and Clinical Oncology, 1987
- Methylprednisolone for the Control of CMF-Induced EmesisAmerican Journal of Clinical Oncology, 1987
- Antiemetic Efficacy of DexamethasoneNew England Journal of Medicine, 1984